Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : T/FIF, a New Plateau -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (2137)	6/14/2003 9:58:51 PM
From: scaram(o)uche	Respond to of 2243

Wow, up 131%. Nice call! Wish I could help you with the investment, overall. I can't, as I don't follow them closely. But...... "One patient in the s.c. group had a similar decrease, not considered an adverse event by the investigator." I think that the investigator is just saying that it's unlikely that s.c. insulin leads to adverse lung events. Silly? So..... 1/53 vs. 2/54...... your focus on digging out the details is smart ("adverse" isn't something one wants to hear at 4% for this), but the numbers aren't anything to worry about????